Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medullary Thyroid Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05675605
What this trial is testing

TY-1091 in Patients With Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more
TYK Medicines, Inc 248
Testing effectiveness (Phase 2)Study completedNCT00098345
What this trial is testing

Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

Who this might be right for
Thyroid Cancer
Genzyme, a Sanofi Company 40
Not applicableStudy completedNCT02465424
What this trial is testing

Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients

Who this might be right for
Medullary Thyroid Cancer
Velindre NHS Trust 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286801
What this trial is testing

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Who this might be right for
Atypical Teratoid/Rhabdoid TumorEpithelioid SarcomaKidney Medullary Carcinoma+15 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT00121628
What this trial is testing

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Amgen 184
Testing effectiveness (Phase 2)Study completedNCT01882816
What this trial is testing

Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 27
Large-scale testing (Phase 3)UnknownNCT01373736
What this trial is testing

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

Who this might be right for
PheochromocytomaNeuroblastomaParaganglioma+2 more
Vancouver Coastal Health
Not applicableUnknownNCT03643055
What this trial is testing

18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
University Medical Centre Ljubljana 80
Not applicableStudy completedNCT04522570
What this trial is testing

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Who this might be right for
Thyroid NeoplasiaWell-Differentiated Thyroid CancerMedullary Thyroid Cancer+1 more
Instituto do Cancer do Estado de São Paulo 84
Not applicableStudy completedNCT05507775
What this trial is testing

Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma

Who this might be right for
Non-Medullary Thyroid Carcinoma
Radboud University Medical Center 8
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more
Novartis Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01856920
What this trial is testing

QUILT-3.006 for Recurrent Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)
NantCell, Inc. 35
Not applicableUnknownNCT03636945
What this trial is testing

Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma

Who this might be right for
Medullary Thyroid Carcinoma
Assistance Publique Hopitaux De Marseille 62
Not applicableAvailableNCT07502716
What this trial is testing

Compassionate Use of Ubamatamab

Who this might be right for
Renal Medullary Carcinoma (RMC)Epithelioid Sarcoma
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Post-approval studies (Phase 4)UnknownNCT01915485
What this trial is testing

Radiolabeled Molecules for Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Instituto Nacional de Cancer, Brazil 20
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Not applicableLooking for participantsNCT03892993
What this trial is testing

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

Who this might be right for
Thyroid Gland Medullary Carcinoma
M.D. Anderson Cancer Center 120
Not applicableStudy completedNCT02268734
What this trial is testing

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

Who this might be right for
Metastatic Sporadic Medullary Thyroid Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 36
Next Page